170643 ⎘
Assays involving biological materials from specific organisms or of a specific nature; Enzymes; Proenzymes; Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7); Phosphotransferases in general; Nucleotidyltransferases (2.7.7) with a definite EC number (2.7.7.-)
ORAL MESENCHYMAL STEM CELLS AND USE THEREOF
#2METHOD FOR DETERMINING THE CONCENTRATION OF INORGANIC PYROPHOSPHATE
#3METHOD AND KIT FOR DETECTING MICRORNA
#4Biomarkers of Marine Invertebrate Stress
#5CLICK-CHEMISTRY BASED BARCODING
#6Amino acid-sensing diguanylate cyclase and methods of use
#7Cancer Detection Method
#8Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
#9Amino acid-sensing diguanylate cyclase and methods of use
#10Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
#11Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
#12Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
#13Method of preparation of nanopore and uses thereof
#14Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
#15ANIMAL MODEL FOR STUDYING ZCCHC6 IN BONE DISEASE AND DEVELOPMENT
#16Method to monitor and quantify interphase nuclear envelope rupture events
#17HIGH-THROUGHPUT SCREENING ASSAY
#18Use of UAP inhibitors to inhibit flux through the hexosamine biosynthetic pathway
#19Methods and compositions for treating degenerative and ischemic disorders
#20Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
#21GENETIC DETECTION PLATFORM
#22Methods and Compositions for Treating Degenerative and Ischemic Disorders
#23Pharmaceutical targeting of a mammalian cyclic di-nucleotide signaling pathway
#24Method of preparation of nanopore and uses thereof
#25PHARMACEUTICAL COMPOSITION FOR VIRAL TREATMENT, AND METHOD FOR SCREENING ANTIVIRAL AGENT
#26RNA-exit-channel: target and method for inhibition of bacterial RNA polymerase
#27Modulation of miRNA Activity
#28Methods and compositions for treating degenerative and ischemic disorders
#29Non-MCCJ25-related lariat-peptide inhibitors of bacterial RNA polymerase
#30Solid-phase chelators and electronic biosensors
#31Recombinant SARS-CoV nsp12 and the use of thereof and the method for producing it
#32METHODS FOR THE IDENTIFICATION OF PARP INTERACTING MOLECULES AND FOR PURIFICATION OF PARP PROTEINS
#33Switch-region: target and method for inhibition of bacterial RNA polymerase
#34METHOD OF DRUG DESIGN
#35Functionalized fluorescent nanocrystal detection system
#36Poly(A) polymerase
#37Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance
#38Methods and compositions for modulating telomerase reverse transcriptase (TERT) expression
#39HCV RNA-dependent RNA polymerase
#40IgY antibodies to human telomerase reverse transcriptase
#41Method for Inhibiting Telomerase Activity and an Agent for Inhibiting the Same
#42Regulatory segments of the human gene for telomerase reverse transcriptase
#43Screening method for a ribonuclease H inhibitor of a reverse transcriptase
#44Assay Method for Drugs to Treat Atherosclerosis, Cancer and Alzheimer's Disease
#45HCV RNA-dependent RNA polymerase
#46Scintillation proximity assay for measuring polymerase activity
#47(+)-TRANS-4-(1-AMINOETHYL)-1-(4-PYRIDYCARBAMOYL)-CYCLOHEXANE AND METHOD FOR PROMOTING NEURAL GROWTH IN THE CENTRAL NERVOUS SYSTEM AND IN A PATIENT AT A SITE OF NEURONAL LESION
#48Materials and methods for the generation of fully 2′-modified nucleic acid transcripts
#49Methods for identifying polymerase inhibitors
#50Methods of detecting poly(adp-ribose) polymerase and other nad+ utilizing enzymes
#51Compositions comprising fungal immunomodulatory protein and use thereof
#52Method and apparatus to facilitate transmission of an encrypted rolling code
#53HCV polymerase suitable for crystal structure analysis and method for using the enzyme
#54Switch-region: target and method for inhibition of bacterial RNA polymerase
#55Method for determining the mechanism of HIV RT inhibitors
#56Compositions for modulation of PARP and methods for screening for same
#57Compositions for treating dental caries caused by streptococcus mutans infection
#58RNA exit channel: target and method for inhibition of bacterial RNA polymerase
#59Crystal of bacterial core RNA polymerase and methods of use thereof
#60In vivo screening methods for identifying inhibitors of RNA polymerases
#61Functionalized fluorescent nanocrystal detection system
#62Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance
#63Compositions and methods for detecting reverse transcriptase in a sample
#64Tyrosyl-tRNA synthetase variants
#65Crystal of bacterial core RNA polymerase with rifampicin and methods of use thereof
#66Diagnostic for scleroderma
#67Fluorescence polarization method for determining viral inhibitors
#68Methods of identifying HCV NS5B polymerase inhibitors and their uses